BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009;49:2214-20. [PMID: 19527477 DOI: 10.1111/j.1537-2995.2009.02245.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Mahmud S, Akbarzadeh V, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses. Sci Rep. 2018;8:150. [PMID: 29317673 DOI: 10.1038/s41598-017-18296-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
2 Rezaee N, Babaeekhou L, Ghane M. Hepatitis C virus in Iran; transmission routes, growth in 3a genotype distribution, and lack of liver marker relation with genotypes. J Res Med Sci 2020;25:96. [PMID: 33273941 DOI: 10.4103/jrms.JRMS_482_19] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Niazkar HR, Dorgalaleh A, Rad F. First-time Blood Donors Are Double-edged Swords for Blood Transfusion Centers: A Retrospective Study in Southwest Iran. Turk J Haematol 2020;37:30-5. [PMID: 31475800 DOI: 10.4274/tjh.galenos.2019.2019.0166] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ameli MR, Hosseini SH, Rad F, Sajjadi SM. Evaluation of the confidential unit exclusion on Iranian blood donors: An 11-year experience. Asian J Transfus Sci 2021;15:57-61. [PMID: 34349458 DOI: 10.4103/ajts.AJTS_152_18] [Reference Citation Analysis]
5 Ogunfemi MK, Olawumi HO, Olokoba AB, Kagu MB, Biliaminu SA, Durowade KA, Durotoye IA, Shittu AO. Prevalence of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative blood donors in Ilorin, Nigeria: A cross-sectional study. Malawi Med J 2017;29:32-6. [PMID: 28567194 DOI: 10.4314/mmj.v29i1.7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Farshadpour F, Taherkhani R, Tajbakhsh S, Gholizadeh Tangestani M, Hajiani G, Sharifi N, Taherkhani S, Nejadbolkheyr A. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study. PLoS One. 2016;11:e0157615. [PMID: 27309959 DOI: 10.1371/journal.pone.0157615] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
7 Said ZNA. An overview of occult hepatitis B virus infection. World J Gastroenterol 2011; 17(15): 1927-1938 [PMID: 21528070 DOI: 10.3748/wjg.v17.i15.1927] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 84] [Article Influence: 8.9] [Reference Citation Analysis]
8 Randriamanantany ZA, Rajaonatahina DH, Razafimanantsoa FÉ, Rasamindrakotroka MT, Andriamahenina R, Rasoarilalaomanarivo FB, Hanitriniala SP, Herisoa FR, Rakoto-Alson OA, Rasamindrakotroka A. Prevalence and trends of hepatitis C virus among blood donors in Antananarivo, from 2003 to 2009. Transfus Clin Biol 2012;19:52-6. [PMID: 22410302 DOI: 10.1016/j.tracli.2011.10.004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Mulugeta H, Dessie G, Wagnew F, Jara D, Leshargie CT, Negesse A. Seroprevalence and trend of human immunodeficiency virus among blood donors in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis 2019;19:383. [PMID: 31060507 DOI: 10.1186/s12879-019-4012-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Salehi Moghadam F, Mohebbi SR, Hosseini SM, Romani S, Mirtalebi H, Azimzadeh P, Damavand B, Naghoosi H, Khanyaghma M, Sanati A, Zali MR. Phylogenetic analysis of hepatitis C virus strains and risk factors associated with infection and viral subtypes among Iranian patients. J Med Virol 2014;86:1342-9. [PMID: 24838700 DOI: 10.1002/jmv.23947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
11 Garmiri P, Rezvan H, Abolghasemi H, Allain JP. Full genome characterization of hepatitis B virus strains from blood donors in Iran. J Med Virol. 2011;83:948-952. [PMID: 21503905 DOI: 10.1002/jmv.21772] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
12 Alavian S, Tabatabaei S, Mahboobi N. Epidemiology and risk factors of HCV infection among hemodialysis patients in countries of the Eastern Mediterranean Regional Office of WHO (EMRO): a quantitative review of literature. J Public Health 2011;19:191-203. [DOI: 10.1007/s10389-010-0366-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
13 Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, Zaer-rezaii H, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R, Esmaili S. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis 2010;14 Suppl 3:e113-6. [PMID: 20362479 DOI: 10.1016/j.ijid.2009.11.032] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 6.1] [Reference Citation Analysis]
14 Kabir K, Hoseini H, Miri M, Amrollahi F, Bahraini E, Afrogh P, Kalantar E. Prevalence of chronic viral hepatitis infections in Karaj, Iran. Pan Afr Med J 2017;28:186. [PMID: 29599884 DOI: 10.11604/pamj.2017.28.186.10269] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Rad F, Sajjadi SM, Azizi A, Maghsudlu M. Confidential unit exclusion (CUE): Double edged sword for blood transfusion center: A ten-year study on volunteer blood donors in Kohgiluyeh and Boyer Ahmad province, Iran. Transfus Clin Biol 2019;26:253-6. [PMID: 31174915 DOI: 10.1016/j.tracli.2019.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Darvish Moghaddam S, Zahedi MJ, Dalili M, Shokoohi M. Compliance of healthcare professionals with safety measures for control of hepatitis viruses in hemodialysis centers: an experience from southeast iran. Hepat Res Treat 2012;2012:415841. [PMID: 23198145 DOI: 10.1155/2012/415841] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Moezzi M, Imani R, Karimi A, Pourheidar B. Hepatitis C Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province of Iran in 2013. J Clin Diagn Res 2015;9:LC13-7. [PMID: 26557546 DOI: 10.7860/JCDR/2015/14986.6694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
18 Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World J Gastroenterol 2015; 21(38): 10790-10810 [PMID: 26478671 DOI: 10.3748/wjg.v21.i38.10790] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
19 Saber HR, Tabatabaee SM, Abasian A, Jamali M, SalekMoghadam E, Hajibeigi B, Alavian SM, Mirrezaie SM. Incidence and Residual Risk of HIV, HBV and HCV Infections Among Blood Donors in Tehran. Indian J Hematol Blood Transfus 2017;33:412-6. [PMID: 28824247 DOI: 10.1007/s12288-016-0732-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
20 Liu Y, Li P, Li C, Zhou J, Wu C, Zhou YH. Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China. Virol J. 2010;7:193. [PMID: 20718994 DOI: 10.1186/1743-422x-7-193] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
21 Akinbami A, Badiru M, Uche E, Onyekwere C, Ismail K, Olowoselu O, Oluwole E, Suleiman A, Augustine B, Olaosebikan H. The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria. Niger Med J 2019;60:22-6. [PMID: 31413431 DOI: 10.4103/nmj.NMJ_29_19] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Hiva S, Negar K, Mohammad-Reza P, Gholam-Reza G, Mohsen A, Ali-Asghar NG, Mohammed-Jafar S. High level of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: a cross-sectional study. BMC Public Health 2020;20:920. [PMID: 32532228 DOI: 10.1186/s12889-020-09032-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Yildiz SM, Candevir A, Kibar F, Karaboga G, Turhan FT, Kis C, Dincer S, Guvenc B. Hepatitis B, Hepatitis C, Human immunodeficiency virus and syphilis frequency among blood donors: A single center study. Transfus Apher Sci 2015;53:308-14. [PMID: 26070837 DOI: 10.1016/j.transci.2015.05.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ji ZH, Li CY, Lv YG, Cao W, Chen YZ, Chen XP, Tian M, Li JH, An QX, Shao ZJ. The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi'an, China between 1999 and 2009. Int J Infect Dis 2013;17:e259-62. [PMID: 23195637 DOI: 10.1016/j.ijid.2012.10.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
25 Seighali F, Divkolaye NSH, Rezaei N, Kangarloo M. Risk factors associated with human immunodeficiency virus infection in blood donors in Iran: A case-control study. Asian J Transfus Sci 2021;15:183-8. [PMID: 34908752 DOI: 10.4103/ajts.AJTS_47_18] [Reference Citation Analysis]
26 Karimi G, Samiei S, Hatami H, Gharehbaghian A, Vafaiyan V, Namini MT. Detection of Chlamydia pneumoniae in peripheral blood mononuclear cells of healthy blood donors in Tehran Regional Educational Blood Transfusion Centre. Transfusion Medicine 2010;20:237-43. [DOI: 10.1111/j.1365-3148.2010.01003.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Behnampour M, Shams M, Hassanzadeh R, Ghaffarian Shirazi H, Naderi H, Kariminejad Z. Using social marketing to persuade Iranians to donate blood. Health Mark Q 2021;:1-10. [PMID: 34229579 DOI: 10.1080/07359683.2021.1940786] [Reference Citation Analysis]
28 Makiani MJ, Davoodian P, Abedi F, Hossini M, Zare S, Rahimi S, Jahanshahi KA, Eftekhari TE. AIDS and hepatitis B and C high risk behaviors among 15 to 45 years old individuals in Bandar Abbas (Iran) in 2012. Electron Physician 2014;6:884-9. [PMID: 25763163 DOI: 10.14661/2014.883-889] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Song Y, Bian Y, Petzold M, Ung CO. Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010. PLoS One 2014;9:e94528. [PMID: 24714490 DOI: 10.1371/journal.pone.0094528] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
30 Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran. Hepat Mon. 2012;12:339-343. [PMID: 22783346 DOI: 10.5812/hepatmon.5969] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
31 Ansari-Moghaddam A, Ostovaneh MR, Sharifi Mood B, Sanei-Moghaddam E, Modabbernia A, Poustchi H. Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study. Hepat Mon 2012;12:e6618. [PMID: 23087764 DOI: 10.5812/hepatmon.6618] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
32 Said ZN, Sayed MHE, Salama II, Aboel-Magd EK, Mahmoud MH, Setouhy ME, Mouftah F, Azzab MB, Goubran H, Bassili A, Esmat GE. Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol 2013; 5(2): 64-73 [PMID: 23646231 DOI: 10.4254/wjh.v5.i2.64] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
33 Mohsenizadeh M, Mollaei HR, Ghaziizadeh M. Seroepidemiological Study of Hepatitis B, C and HIV among Blood Donors in Kerman. Asian Pac J Cancer Prev 2017;18:3267-72. [PMID: 29286218 DOI: 10.22034/APJCP.2017.18.12.3267] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
34 Zhong L, Xi G, Zhang L, Liu S, Wan L, Yu L, Zhou M, Zhang J, He Y. The estimation of prevalence and risk factors of hepatitis B virus infection among blood donors in Chengdu, China. J Med Virol 2016;88:260-7. [PMID: 26241150 DOI: 10.1002/jmv.24339] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
35 Javadzadeh Shahshahani H, Taghvai N. Blood wastage management in a regional blood transfusion centre: Blood wastage management in blood centre. Transfusion Med 2017;27:348-53. [DOI: 10.1111/tme.12433] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
36 Zamani F, Sohrabi M, Poustchi H, Keyvani H, Saeedian FS, Ajdarkosh H, Khoonsari M, Hemmasi G, Moradilakeh M, Motamed N, Maadi M. Prevalence and risk factors of hepatitis C virus infection in amol city, north of iran: a population-based study (2008-2011). Hepat Mon 2013;13:e13313. [PMID: 24358039 DOI: 10.5812/hepatmon.13313] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
37 Azadbakht M, Ardakani MT, Delirakbariazar M, Kasraian L, Khaledi A, Foruozandeh H, Salah A, Maleki F, Eshraghi M. Seroprevalence and Trend of HBV, HCV, and HIV Infections among Blood Donors of Fars Province, Iran (2006-2018). Ethiop J Health Sci 2020;30:397-408. [PMID: 32874083 DOI: 10.4314/ejhs.v30i3.11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Poustchi H, Esmaili S, Mohamadkhani A, Nikmahzar A, Pourshams A, Sepanlou SG, Merat S, Malekzadeh R. The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study. PLoS One 2011;6:e23830. [PMID: 21887326 DOI: 10.1371/journal.pone.0023830] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
39 Keshvari M, Sharafi H, Alavian SM, Mehrabadi H, Zolfaghari S. Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013. Transfus Apher Sci 2015;53:38-47. [PMID: 25892591 DOI: 10.1016/j.transci.2015.03.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
40 Rezaei N, Amini-Kafiabad S, Maghsudlu M, Abolghasemi H. Risk factor analysis of hepatitis C virus seropositivity in Iranian blood donors: a case-control study. Transfusion 2016;56:1891-8. [PMID: 27273657 DOI: 10.1111/trf.13660] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
41 Babanejad M, Izadi N, Najafi F, Alavian SM. The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon 2016;16:e35664. [PMID: 27226804 DOI: 10.5812/hepatmon.35664] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
42 Melhem NM, Rahhal N, Charide R, Kreidieh K, El-Khatib R. Human immunodeficiency virus and viral hepatitis among high-risk groups: Understanding the knowledge gap in the Middle East and North Africa Region. World J Hepatol 2015; 7(25): 2619-2630 [PMID: 26557955 DOI: 10.4254/wjh.v7.i25.2619] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
43 Sarbandi H, Hosseini SM, Vakili K, Fathi M, Deravi NV, Vaezjalali M. [Hepatitis B Virus (Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus) among Hospitalized Mentally Disabled Patients is not transmitted by their nurses or family members]. Vopr Virusol 2021;65:350-6. [PMID: 33533231 DOI: 10.36233/0507-4088-2020-65-6-5] [Reference Citation Analysis]
44 Vasmehjani AA, Yaghubi S, Erfani Y, Hajikhezri Z, Farahmand M, Shayestehpour M, Adeli OA, Beiranvand M. Trend in Prevalence of Hepatitis B Virus Infection Among Blood Donor Individuals: An Eleven-year of Experience in Lorestan, Iran. Int J Prev Med 2020;11:178. [PMID: 33456734 DOI: 10.4103/ijpvm.IJPVM_260_18] [Reference Citation Analysis]
45 Ramezani H, Bozorgi SH, Nooranipour M, Sadri M, Molaverdikhani S, Alavian SM. Successful exclusion of blood-borne viral disease in blood donors. Eur J Intern Med 2011;22:e71-4. [PMID: 22075316 DOI: 10.1016/j.ejim.2011.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
46 Nna E, Mbamalu C, Ekejindu I. Occult hepatitis B viral infection among blood donors in South-Eastern Nigeria. Pathog Glob Health 2014;108:223-8. [PMID: 24995918 DOI: 10.1179/2047773214Y.0000000144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
47 Norouzian H, Gholami M, Shakib P, Goudarzi G, Ghobadian Diali H, Rezvani A. Prevalence of HCV Infections and Co-Infection With HBV and HIV and Associated Risk Factors Among Addicts in Drug Treatment Centers, Lorestan Province, Iran. Int J High Risk Behav Addict 2016;5:e25028. [PMID: 27162762 DOI: 10.5812/ijhrba.25028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
48 Azarkeivan A, Toosi MN, Maghsudlu M, Kafiabad SA, Hajibeigi B, Hadizadeh M. The incidence of hepatitis C in patients with thalassemia after screening in blood transfusion centers: a fourteen-year study. Transfusion 2012;52:1814-8. [PMID: 22500658 DOI: 10.1111/j.1537-2995.2012.03652.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
49 Tahaei SM, Mohebbi SR, Azimzadeh P, Vahedi M, Almasi S, Romani S, Sharifian A, Derakhshan F, Zali MR. Frequency of HIV and HCV Co-Infections in Chronic HBV Patients Referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010. Hepat Mon. 2011;11:993-996. [PMID: 22368684 DOI: 10.5812/kowsar.1735143x.740] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Rezaei N, Maghsodlu M, Sheidaei A, Kafiabad SA, Gohari K, Zadsar M, Delavari F, Sharifi Z, Yoosefi M, Farzadfar F, Asadi-Lari M. Spatio-Temporal Analysis of the Hepatitis B Prevalence in Iranian Blood Donors from 2000 to 2016 at National and Provincial Level. Iran J Public Health 2021;50:1854-62. [PMID: 34722381 DOI: 10.18502/ijph.v50i9.7058] [Reference Citation Analysis]
51 Omidkhoda A, Razi B, Arabkhazaeli A, Amini Kafi-Abad S. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety. BMC Infect Dis 2020;20:736. [PMID: 33028232 DOI: 10.1186/s12879-020-05405-9] [Reference Citation Analysis]
52 Liu Y, Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect. 2010;118:818-824. [PMID: 20172840 DOI: 10.1289/ehp.0901388] [Cited by in Crossref: 559] [Cited by in F6Publishing: 439] [Article Influence: 46.6] [Reference Citation Analysis]
53 Keyvani H, Sohrabi M, Zamani F, Poustchi H, Ashrafi H, Saeedian F, Mooadi M, Motamed N, Ajdarkosh H, Khonsari M, Hemmasi G, Ameli M, Kabir A, Khodadost M. A population based study on hepatitis B virus in northern iran, amol. Hepat Mon 2014;14:e20540. [PMID: 25237372 DOI: 10.5812/hepatmon.20540] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
54 Flichman DM, Blejer JL, Livellara BI, Re VE, Bartoli S, Bustos JA, Ansola CP, Hidalgo S, Cerda ME, Levin AE, Huenul A, Riboldi V, Treviño EM, Salamone HJ, Nuñez FA, Fernández RJ, Reybaud JF, Campos RH. Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors. BMC Infect Dis 2014;14:218. [PMID: 24755089 DOI: 10.1186/1471-2334-14-218] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
55 Khazaei S, Karami M, Ayubi E, Mohammadbeigi A, Hasanbeigi A, Mansori K, Mir-Shekar MR. Trends in epidemiology of Hepatitis B and C Infections in Ilam Province: National Notifiable Diseases Surveillance System data. Caspian J Intern Med 2018;9:16-21. [PMID: 29387314 DOI: 10.22088/cjim.9.1.16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
56 Abedi F, Madani H, Asadi A, Nejatizadeh A. Significance of blood-related high-risk behaviors and horizontal transmission of hepatitis B virus in Iran. Arch Virol 2011;156:629-35. [PMID: 21229276 DOI: 10.1007/s00705-010-0902-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
57 Omidkhoda A, Amini Kafi-abad S, Pourfatollah AA, Maghsudlu M. Blood collection, components preparation and distribution in Iran, 2008–2012. Transfusion and Apheresis Science 2016;54:117-21. [DOI: 10.1016/j.transci.2016.01.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
58 Nakhla IA, Sanders JW, Mohareb EW, Samy S, Cosby MT, Mostafa MM, Riddle MS, Frenck RW Jr. A cross-sectional household cluster serosurvey of hepatitis C virus antibodies in an urban slum of Cairo, Egypt in 2004. Trop Dis Travel Med Vaccines 2015;1:9. [PMID: 28883941 DOI: 10.1186/s40794-015-0012-7] [Reference Citation Analysis]
59 Ramia S, Melhem NM, Kreidieh K. Hepatitis C virus infection in the Middle East and North Africa “MENA” region: injecting drug users (IDUs) is an under-investigated population. Infection. 2012;40:1-10. [PMID: 22237470 DOI: 10.1007/s15010-011-0236-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
60 Sood AK, Pangotra C, Manrai M. Prevalence of occult hepatitis B infection in patients visiting tertiary care hospital. Med J Armed Forces India 2016;72:140-4. [PMID: 27257324 DOI: 10.1016/j.mjafi.2016.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
61 Taheri Soodejani M, Haghdoost AA, Sedaghat A, Baneshi MR, Zolala F. The Trends of Viral Hepatitis B and C and HIV Infections in Donated Bloods in Iran Between 2003 and 2017. J Blood Med 2019;10:435-41. [PMID: 31908558 DOI: 10.2147/JBM.S229327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Emadi B, Ghahraman Rezaieh M, Sedighi M. Seroprevalence and trends of transfusion transmissible infections among retrospective blood donors in Western Azerbaijan Regional Blood Transfusion Center, Iran: A ten-years evaluation. Transfus Apher Sci 2021;60:103132. [PMID: 33846093 DOI: 10.1016/j.transci.2021.103132] [Reference Citation Analysis]
63 Abbasi S, Makvandi M, Karimi G, Neisi N. The Prevalence of SEN Virus and Occult Hepatitis B (OBI) Virus Infection Among Blood Donors in Ahvaz City. Jundishapur J Microbiol 2016;9:e37329. [PMID: 27679708 DOI: 10.5812/jjm.37329] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
64 Amini-Kafiabad S, Pourfatollah AA. Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006-2015. Transfus Med 2021. [PMID: 34820928 DOI: 10.1111/tme.12833] [Reference Citation Analysis]